United States · FDA National Drug Code directory
Sincalide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72266-248_187381ab-f66f-7a22-e063-6294a90a262a
- Product NDC
- 72266-248
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Sincalide
- Labeler
- FOSUN PHARMA USA INC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230109
- Source listing expiry
- 20261231
Source-listed ingredients
- SINCALIDE — 5 ug/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 VIAL in 1 PACKAGE (72266-248-05) / 5 mL in 1 VIAL (72266-248-01) · 72266-248-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →